ÄúÕýÔÚ·ÃÎÊÑÇ»ãÍøÏã¸Û·ÖÕ¾£¬±¾Õ¾ËùÌṩµÄÄÚÈݾù×ñÊØÖлªÈËÃñ¹²ºÍ¹úÏã¸ÛÌØ±ðÐÐÕþÇø·¨ÂÉ·¨¹æ¡£

Ò°´å£ºÉýº²É­ÖÆÒ©(03692)Ä¿±ê¼ÛÖÁ25.64¸ÛÔª ά³Ö¡°ÖÐÐÔ¡±ÆÀ¼¶

ÎÄ / СÑÇ 2025-06-03 23:02:36 À´Ô´:ÑÇ»ãÍø

Ò°´å·¢²¼Ñб¨³Æ£¬ÓÉÓÚ¹ÀÖµ½Ï¸ß£¬½«º²É­ÖÆÒ©(03692)Ä¿±ê¼Û´Ó19.86¸ÛÔªÉϵ÷29%ÖÁ25.64¸ÛÔª£¬²¢Î¬³Ö¡°ÖÐÐÔ¡±ÆÀ¼¶¡£±¨¸æÖ¸£¬6ÔÂ2ÈÕ£¬º²É­ÖÆÒ©Ðû²¼½«ÆäGLP-1/GIPË«ÖØ¼¤¶¯¼ÁHS-20094ÊÚȨ¸øÓëRegeneronPharmaceuticals£¬Inc¡£ºóÕß½«Ïò¼¯ÍÅÖ§¸¶8000ÍòÃÀÔªÔ¤¸¶¿î¡¢×î¸ß19.3ÒÚÃÀÔªµÄÀï³Ì±®¸¶¿î£¬ÒÔ¼°10%×óÓÒµÄÏúÊÛÌá³É£¬ÒÔ»ñµÃ¸ÃIIIÆÚÁÙ´²Ñо¿·Ö×ÓÔÚ´óÖлªÇøÒÔÍâµÄȨÀû£¬ÒòÓ¦¿ÉÄܲÆÎñ¹±Ï×£¬Éϵ÷Ä¿±ê¼Û¡£

Ïà¹ØÐÂÎÅ

¼ÓÔØ¸ü¶à...

ÅÅÐаñ ÈÕÅÅÐÐ | ÖÜÅÅÐÐ